Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Dutta

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Clinical Pharmacology in Drug Development|February 29, 2024
Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of SotorasibPanli Cardona, Sandeep Dutta, Brett Houk
Journal of Clinical Pharmacology|May 2, 2015
Small-molecule compounds exhibiting target-mediated drug disposition - A case example of ABT-384Guohua An, Wei Liu, Sandeep Dutta
Clinical Pharmacology in Drug Development|July 17, 2024
Impact of a High-Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C InhibitorPanli Cardona, Sandeep Dutta, Brett Houk
Epilepsy Research|November 7, 2009
Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapyRonald Charles Reed, Sandeep Dutta, Wei Liu
Advances in Therapy|June 21, 2021
Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid TumorsJohannes Kast, Sandeep Dutta, Vijay V Upreti
Journal of Clinical Pharmacology|June 17, 2004
Absolute bioavailability and absorption characteristics of divalproex sodium extended-release tablets in healthy volunteersSandeep Dutta, Ronald C Reed, John H Cavanaugh
The Annals of Pharmacotherapy|March 30, 2006
Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implicationsSandeep Dutta, Ronald C Reed, Robert F O'Dea
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2004
Pharmacokinetics and safety of extended-release divalproex sodium tablets: morning versus evening administrationSandeep Dutta, Ronald C Reed, John H Cavanaugh
The AAPS Journal|February 14, 2012
Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic painSandeep Dutta, Balakrishna S Hosmane, Walid M Awni
European Journal of Drug Metabolism and Pharmacokinetics|May 9, 2002
Effect of food on the pharmacokinetics of fiduxosin in healthy male subjectsSandeep Dutta, Yiming Zhang, G Richard Granneman, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Clinical Pharmacology in Drug Development|February 29, 2024
Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of SotorasibPanli Cardona, Sandeep Dutta, Brett Houk
Journal of Clinical Pharmacology|May 2, 2015
Small-molecule compounds exhibiting target-mediated drug disposition - A case example of ABT-384Guohua An, Wei Liu, Sandeep Dutta
Clinical Pharmacology in Drug Development|July 17, 2024
Impact of a High-Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C InhibitorPanli Cardona, Sandeep Dutta, Brett Houk
Epilepsy Research|November 7, 2009
Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapyRonald Charles Reed, Sandeep Dutta, Wei Liu
Advances in Therapy|June 21, 2021
Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid TumorsJohannes Kast, Sandeep Dutta, Vijay V Upreti
Journal of Clinical Pharmacology|June 17, 2004
Absolute bioavailability and absorption characteristics of divalproex sodium extended-release tablets in healthy volunteersSandeep Dutta, Ronald C Reed, John H Cavanaugh
The Annals of Pharmacotherapy|March 30, 2006
Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implicationsSandeep Dutta, Ronald C Reed, Robert F O'Dea
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2004
Pharmacokinetics and safety of extended-release divalproex sodium tablets: morning versus evening administrationSandeep Dutta, Ronald C Reed, John H Cavanaugh
The AAPS Journal|February 14, 2012
Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic painSandeep Dutta, Balakrishna S Hosmane, Walid M Awni
European Journal of Drug Metabolism and Pharmacokinetics|May 9, 2002
Effect of food on the pharmacokinetics of fiduxosin in healthy male subjectsSandeep Dutta, Yiming Zhang, G Richard Granneman, et al.
Pageof 12